Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research.

Current Issue

October 2023 (Vol. 43 Issue 10) Table of Contents
Anticancer Research: 43 (10)

Issue highlights

  • High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
  • The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review
  • Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells
  • Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRASG12D Inhibitor, in Colorectal Cancer Treatment
  • Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm)

 


 

Special Issue of ANTICANCER RESEARCH on New Anticancer Agents - 2024

Topics:

A. Experimental studies on "New Anticancer Agents":

                     1. Synthesis and evaluation in vitro and in vivo

                     2. Mechanism of action

                     3. Reversal of resistance to anticancer agents

                     4. Oncolytic viruses

 

B. Clinical studies on "New Anticancer Agents":

                      1. Pharmacology

                      2. Clinical trials

                      3. Combination chemotherapy

                      4. Immunotherapeutic agents

                      5. New methodologies in drug delivery

                      6. Vaccines

 

Publication date: March 1, 2024

Submission deadline: December 31, 2023

Instructions for the preparation and submission of reviews and original articles: www.iiar-anticancer.org

Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • You have access
    miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2
    PING REN, NA WU, SHICHEN FU, WENBIN WANG, QI LI and QINGZHOU CHENG
    Anticancer Research October 2023, 43 (10) 4379-4388; DOI: https://doi.org/10.21873/anticanres.16634
  • You have access
    The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate Cancer
    FUMIHIKO URABE, DAIGO KOBAYASHI, KOSUKE IWATANI, YU IMAI, HAJIME ONUMA, KOICHI AIKAWA, TAKAFUMI YANAGISAWA, KOJIRO TASHIRO, HIROSHI SASAKI, JUN MIKI, KENTA MIKI and TAKAHIRO KIMURA
    Anticancer Research October 2023, 43 (10) 4611-4617; DOI: https://doi.org/10.21873/anticanres.16655
  • You have access
    Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid
    JR-DI YANG, PO-FU YUEH, TSAI LAN LIAO, YING-TZU CHEN, FEI-TING HSU, I-TSANG CHIANG, CHING MING CHANG and WEI-SHU WANG
    Anticancer Research October 2023, 43 (10) 4403-4412; DOI: https://doi.org/10.21873/anticanres.16636
  • Open Access
    High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
    TAKASHI HIGUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research October 2023, 43 (10) 4277-4284; DOI: https://doi.org/10.21873/anticanres.16622
  • You have access
    Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules
    PORNNAPAT CHUSANGNIN, THARATHIP MUANGTHONG, WITCHUDA PAYUHAKRIT, SARAWOOT PALIPOCH and PRASIT SUWANNALERT
    Anticancer Research October 2023, 43 (10) 4461-4472; DOI: https://doi.org/10.21873/anticanres.16641
  • Open Access
    Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis
    FAUSTO PETRELLI, CARMEN REA, MARIA CHIARA PARATI, KAREN BORGONOVO, MARA GHILARDI, LORENZO DOTTORINI, ANDREA LUCIANI, MICHELE GHIDINI, FIORELLA RUATTA, ORNELLA GARRONE and GIANLUCA TOMASELLO
    Anticancer Research October 2023, 43 (10) 4303-4313; DOI: https://doi.org/10.21873/anticanres.16625
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire